2m 2m 2m 2m 2m 2m 2m
CRINETICS PHARMA (CRNX)
NASDAQ
$36.07+$0.68 (+1.94%)
Price as of Jun 23, 2026 6:47 PM EDT- $3.7BMarket Cap
- 18.29%1-Year Change
- BiotechnologyIndustry
CRINETICS PHARMA (CRNX)
$36.07+$0.68 (+1.94%)
Earnings Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 0.61% | ||
12-Month Momentum | 20.26% | ||
3-Month Risk Adjusted Momentum | 2.58% | ||
12-Month Risk Adjusted Momentum | 36.20% |
True Yield
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |